James L. Januzzi, MD, reflects on the disparate health outcomes related to social determinants that cascade across the diagnostic and therapeutic spectrum of heart failure. He remarks that the advanced therapies developed to treat heart failure will remain unavailable to many patients owing to their prohibitive costs.
Dr Januzzi urges clinicians to focus on overcoming the disparities rooted in the cause and progression of heart failure, and then intervening in terms of health equity in order to reduce incidence in these communities.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Preventing the "Biggest Advances" in the Treatment of Heart Failure From Becoming the "Biggest Failures" - Medscape - Dec 13, 2022.
Comments